| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.13 | 0.5 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.13 | 0.5 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.5 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.12 | 0.5 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.5 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |